Return On Equity of Serina Therapeutics, Inc. from 31 Dec 2018 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Serina Therapeutics, Inc. quarterly and annual Return On Equity in % history and change rate from 31 Dec 2018 to 30 Sep 2025.
  • Serina Therapeutics, Inc. Return On Equity for the quarter ending 30 Sep 2025 was -1401%, a 4431% decline year-over-year.
  • Serina Therapeutics, Inc. annual Return On Equity for 2024 was 77%.
  • Serina Therapeutics, Inc. annual Return On Equity for 2023 was -15%, a 129% decline from 2022.
  • Serina Therapeutics, Inc. annual Return On Equity for 2022 was 54%, a 44% decline from 2021.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Change (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Change (%)

Serina Therapeutics, Inc. Quarterly Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 -1401% -1433% -4431% 01 Jul 2025 30 Sep 2025
Q2 2025 498% +473% +1861% 01 Apr 2025 30 Jun 2025
Q1 2025 13% -22% -62% 01 Jan 2025 31 Mar 2025
Q4 2024 77% +92% 01 Oct 2024 31 Dec 2024
Q3 2024 32% +37% 01 Jul 2024 30 Sep 2024
Q2 2024 25% +17% +195% 01 Apr 2024 30 Jun 2024
Q1 2024 35% +11% +48% 01 Jan 2024 31 Mar 2024
Q4 2023 -15% -69% -129% 01 Oct 2023 31 Dec 2023
Q3 2023 -4.2% -81% -106% 01 Jul 2023 30 Sep 2023
Q2 2023 8.6% -72% -89% 01 Apr 2023 30 Jun 2023
Q1 2023 24% -65% -73% 01 Jan 2023 31 Mar 2023
Q4 2022 54% -42% -44% 01 Oct 2022 31 Dec 2022
Q3 2022 76% -44% -37% 01 Jul 2022 30 Sep 2022
Q2 2022 81% -81% -50% 01 Apr 2022 30 Jun 2022
Q1 2022 89% -136% -60% 01 Jan 2022 31 Mar 2022
Q4 2021 96% -278% -74% 01 Oct 2021 31 Dec 2021
Q3 2021 120% -1107% -90% 01 Jul 2021 30 Sep 2021
Q2 2021 162% +725% 01 Apr 2021 30 Jun 2021
Q1 2021 225% +560% 01 Jan 2021 31 Mar 2021
Q4 2020 373% +568% 01 Oct 2020 31 Dec 2020
Q3 2020 1228% +1393% 01 Jul 2020 30 Sep 2020
Q2 2020 -562% -435% -343% 01 Apr 2020 30 Jun 2020
Q1 2020 -335% -234% -231% 01 Jan 2020 31 Mar 2020
Q4 2019 -195% -120% -160% 01 Oct 2019 31 Dec 2019
Q3 2019 -165% 01 Jul 2019 30 Sep 2019
Q2 2019 -127% 01 Apr 2019 30 Jun 2019
Q1 2019 -101% 01 Jan 2019 31 Mar 2019
Q4 2018 -75% 01 Oct 2018 31 Dec 2018

Serina Therapeutics, Inc. Annual Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
2024 77% +92% 01 Jan 2024 31 Dec 2024
2023 -15% -69% -129% 01 Jan 2023 31 Dec 2023
2022 54% -42% -44% 01 Jan 2022 31 Dec 2022
2021 96% -278% -74% 01 Jan 2021 31 Dec 2021
2020 373% +568% 01 Jan 2020 31 Dec 2020
2019 -195% -120% -160% 01 Jan 2019 31 Dec 2019
2018 -75% 01 Jan 2018 31 Dec 2018
* An asterisk sign (*) next to the value indicates that the value is likely invalid.